Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Histone modification is key in treating chronic inflammatory skin diseases.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Fungi-produced compounds can change plant root growth.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New treatments for severe alopecia areata show promise but lack standard approval.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.